Dow Up0.03% Nasdaq Up0.02%

Amorfix Life Sciences Ltd. (AMF.TO)

0.29 0.00(0.00%) 11:16AM EDT
ProfileGet Profile for:
Amorfix Life Sciences Ltd.
3403 American Drive
Mississauga, ON L4V 1T4
Canada - Map
Phone: 416-847-6898
Fax: 416-847-6899

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:N/A

Business Summary 

Amorfix Life Sciences Ltd. develops therapeutic products and diagnostic devices for misfolded protein diseases in Canada. It develops antibodies and vaccines for the treatment of Amyotrophic Lateral Sclerosis (ALS) and various types of cancer. The company's diagnostic programs include EP-AD CSF Diagnostic Test, an assay for the detection of the aggregated form of Aß in human cerebrospinal fluid and mild cognitive impairment; A4, an ultra-sensitive assay for detecting aggregated Aß in animal models of Alzheimer's disease (AD); blood test for use as a diagnostic tool for ALS; and ProMIS, a computer based algorithm that predicts disease specific epitopes. It also offers custom assay development services. The company also has strategic alliances with Epitomics Inc. to develop immunotherapeutics to various proteins; and license agreement with Biogen Idec for developing therapeutics to treat ALS. Amorfix Life Sciences Ltd. is headquartered in Mississauga, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Amorfix Life Sciences Ltd.

Key Executives 
Dr. Robert H. Gundel Ph.D., M.B.A., 59
Chief Exec. Officer, Pres, Director and Member of Financing Committee
Dr. Neil Cashman M.D.,
Founder, Chairman of Scientific Advisory Board, Chief Scientific Officer, Director and Member of Financing Committee
Mr. Warren Whitehead C.M.A., 62
Chief Financial Officer
Prof. Walter P. Von Wartburg Ph.D., 74
Sr. Advisor, Director and Member of Audit Committee
Louise Scrocchi ,
Associate Director of R&D
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.
View Insiders